Keywords: recombinant, solution, hemophilia, patients, genetics, institute, started

Recombinant Solution For Hemophilia B Patients

Article | 31 July 1995

Print This

Genetics Institute has started Phase III trials of its recombinant human Factor IX product for the treatment of hemophilia B. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in